An international randomised trial found fewer cases of acute kidney injury with cefazolin than with flucloxacillin or cloxacillin, while meeting its survival noninferiority threshold.
A Novartis oral pill for relapsing multiple sclerosis outperformed standard therapy in two large Phase III trials, and unlike a rival BTK inhibitor the FDA declined over liver concerns, it showed no liver safety signal. Here is what the REMODEL
An oral GLP-1 pill produced 12.1% body weight loss over 36 weeks without injections or fasting, Phase 2b data in Nature Medicine shows. Results push aleniglipron to the front rank of oral
A year-long randomized clinical trial found omega-3 fatty acids and low-dose aspirin matched antibiotics for severe gum disease — offering an antibiotic-sparing option in a field where overuse of antimicrobials is increasingly
A Washington University clinical trial found all three diets produced 10% weight loss — but keto cut liver fat 67%, far outpacing Mediterranean's 45%, and reversed prediabetes in half of participants without
Researchers at Charité – Universitätsmedizin Berlin have published the world's first clinical trial of CAR T-cell therapy for severe rheumatoid arthritis, reporting that all six patients showed improvement and three achieved sustained
A Phase 1 trial at Charité Berlin found a single CD19 CAR T-cell infusion achieved medication-free remission in three of six treatment-resistant rheumatoid arthritis patients, the first peer-reviewed evidence of its kind
The FDA approved daraxonrasib on August 26 as the first broad RAS inhibitor for metastatic pancreatic cancer, ending a 40-year search for a drug to silence the mutations that drive 90 percent
A 6-year-old with Snijders Blok-Campeau syndrome died in March 2025 after an unauthorized CRISPR brain surgery trial in Shanghai, her death concealed for 14 months. Shanghai Jiao Tong University opened a formal
A CBS News reporter purchased Eli Lilly's experimental weight-loss drug retatrutide at a Brooklyn convenience store for $95 with no prescription as toxicity reports rise and the FDA warns such products are
Researchers enrolled the first patient Thursday in Congo's Ituri province, testing remdesivir and MBP134 against the Bundibugyo Ebola strain that has infected more than 1,400 people and killed 438. Africa CDC is
The World Health Organization has enrolled the first patients in the PARTNERS trial, testing remdesivir and a monoclonal antibody against a Bundibugyo virus outbreak that has killed more than 440 people in
Follow